Molecular Imaging

Molecular Imaging

To Better Manage Disease

Working with leading biotechnology and pharmaceutical companies, MDS Nordion is leading the way in the application of molecular imaging to improve the health and well-being of people. Advances in molecular and cell biology combined with powerful, non-invasive imaging technologies provide physicians and researchers with critical information. Information that enables:

  • Detection, diagnosis and treatment at the earliest stages of disease;
  • Faster and more effective identification of lead drug compounds; and
  • More efficient development of new therapeutics to treat disease.

Molecular imaging can be applied at all stages of drug discovery and development – from validating disease-relevant targets to pre-clinical evaluation and selection of drug candidates – through to clinical development and post-marketing surveillance.

Learn more about our customized molecular imaging services. To contact us click here.